Literature DB >> 24371387

Photodynamic therapy with ablative carbon dioxide fractional laser in treatment of actinic keratosis.

Yong Hyun Jang1, Dong Jun Lee2, Jaeyoung Shin2, Hee Young Kang2, Eun-So Lee2, You Chan Kim2.   

Abstract

BACKGROUND: Recently, photodynamic therapy (PDT) has been shown to be an effective first-line treatment for actinic keratosis (AK). However, a major limitation of PDT is the long incubation time required to allow penetration of the photosensitizer.
OBJECTIVE: The aim of this study was to assess if pretreatment with an ablative carbon dioxide (CO2) fractional laser can reduce the incubation time of the photosensitizer.
METHODS: Initially, 29 patients with a total of 34 AK lesions were treated with an ablative CO2 fractional laser at Ajou University Hospital between January and December 2010. Immediately after the laser treatment, topical 20% 5-aminolevulinic acid or methyl-aminolevulinate was applied to the AK lesions and incubated for 70 to 90 minutes. Then, the treated areas were illuminated with a red light source. Improvement was clinically or histologically assessed eight weeks after the treatment.
RESULTS: In spite of the short incubation time, 24 lesions (70.6%) showed a complete response (CR) within three sessions of PDT (10 lesions a clinical CR and 14 lesions a clinical/histological CR). There were no significant side effects associated with the combination of ablative CO2 fractional laser and PDT.
CONCLUSION: Ablative CO2 fractional laser may be considered an additional treatment option for reducing the incubation time of the photosensitizer in PDT.

Entities:  

Keywords:  Actinic keratosis; Carbon dioxide lasers; Photochemotherapy

Year:  2013        PMID: 24371387      PMCID: PMC3870208          DOI: 10.5021/ad.2013.25.4.417

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


  18 in total

1.  Topical delta-aminolevulinic acid-based photodynamic therapy for Japanese actinic keratoses.

Authors:  Y Itoh; Y Ninomiya; T Henta; S Tajima; A Ishibashi
Journal:  J Dermatol       Date:  2000-08       Impact factor: 4.005

Review 2.  Photodynamic therapy in skin rejuvenation.

Authors:  David J Goldberg
Journal:  Clin Dermatol       Date:  2008 Nov-Dec       Impact factor: 3.541

Review 3.  Photodynamic therapy in dermatology: an update on applications and outcomes.

Authors:  Mollie A MacCormack
Journal:  Semin Cutan Med Surg       Date:  2008-03

Review 4.  Methyl aminolevulinate-PDT for actinic keratoses and superficial nonmelanoma skin cancers.

Authors:  B Ortiz-Policarpio; H Lui
Journal:  Skin Therapy Lett       Date:  2009 Jul-Aug

5.  Physicochemical and safety evaluation of 5-aminolevulinic acid in novel liposomes as carrier for skin delivery.

Authors:  Yi-Ping Fang; Pao-Chu Wu; Yi-Hung Tsai; Yaw-Bin Huang
Journal:  J Liposome Res       Date:  2008       Impact factor: 3.648

6.  Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study.

Authors:  R M Szeimies; S Karrer; S Radakovic-Fijan; A Tanew; P G Calzavara-Pinton; C Zane; A Sidoroff; M Hempel; J Ulrich; T Proebstle; H Meffert; M Mulder; D Salomon; H C Dittmar; J W Bauer; K Kernland; L Braathen
Journal:  J Am Acad Dermatol       Date:  2002-08       Impact factor: 11.527

7.  Enhancement of topical 5-aminolaevulinic acid delivery by erbium:YAG laser and microdermabrasion: a comparison with iontophoresis and electroporation.

Authors:  J-Y Fang; W-R Lee; S-C Shen; Y-P Fang; C-H Hu
Journal:  Br J Dermatol       Date:  2004-07       Impact factor: 9.302

Review 8.  Fractional photothermolysis--an update.

Authors:  Inja Bogdan Allemann; Joely Kaufman
Journal:  Lasers Med Sci       Date:  2010-01       Impact factor: 3.161

Review 9.  Photodynamic therapy in dermatology--an update 2008.

Authors:  Annette Klein; Philipp Babilas; Sigrid Karrer; Michael Landthaler; Rolf-Markus Szeimies
Journal:  J Dtsch Dermatol Ges       Date:  2008-04-09       Impact factor: 5.584

10.  Enhanced efficacy of photodynamic therapy with methyl 5-aminolevulinic acid in recalcitrant periungual warts after ablative carbon dioxide fractional laser: a pilot study.

Authors:  Kwang Ho Yoo; Beom Joon Kim; Myeung Nam Kim
Journal:  Dermatol Surg       Date:  2009-12       Impact factor: 3.398

View more
  5 in total

Review 1.  Photodynamic Therapy with 5-aminolevulinic Acid 10% Gel and Red Light for the Treatment of Actinic Keratosis, Nonmelanoma Skin Cancers, and Acne: Current Evidence and Best Practices.

Authors:  Nathalie C Zeitouni; Neal Bhatia; Roger I Ceilley; Joel L Cohen; James Q Del Rosso; Angela Y Moore; Gilly Munavalli; David M Pariser; Todd Schlesinger; Daniel M Siegel; Andrea Willey; Mitchel P Goldman
Journal:  J Clin Aesthet Dermatol       Date:  2021-10

2.  A Case of Bowen's Disease Successfully Treated with Ingenol Mebutate Gel.

Authors:  Je-Byeong Chae; Jung-Tae Park; Bo-Ri Kim; Chang-Hun Huh; Kyoung-Chan Park; Jung-Won Shin
Journal:  Ann Dermatol       Date:  2017-06-21       Impact factor: 1.444

3.  Ablative Fractional Radiofrequency Combined with Sonophoresis Increases Skin Penetration of Indocyanine Green.

Authors:  Hee-Kyeong Lim; Ki-Heon Jeong; Min Kyung Shin
Journal:  Ann Dermatol       Date:  2015-05-29       Impact factor: 1.444

4.  Ingenol mebutate in low amounts for the treatment of actinic keratosis in Korean patients.

Authors:  Hyun Jae Joe; Byung Ho Oh
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-03-30

Review 5.  Combination-Based Strategies for the Treatment of Actinic Keratoses with Photodynamic Therapy: An Evidence-Based Review.

Authors:  Stefano Piaserico; Roberto Mazzetto; Emma Sartor; Carlotta Bortoletti
Journal:  Pharmaceutics       Date:  2022-08-18       Impact factor: 6.525

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.